Logo image of CHSCP

CHS INC - CHSINC 8 PERP (CHSCP) Stock Fundamental Analysis

NASDAQ:CHSCP - US12542R2094

28.75 USD
-0.14 (-0.48%)
Last: 8/28/2025, 4:10:09 PM
Fundamental Rating

3

Taking everything into account, CHSCP scores 3 out of 10 in our fundamental rating. CHSCP was compared to 90 industry peers in the Food Products industry. While CHSCP is still in line with the averages on profitability rating, there are concerns on its financial health. CHSCP has a expensive valuation and it also scores bad on growth. CHSCP also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CHSCP had a positive operating cash flow in the past year.
Each year in the past 5 years CHSCP has been profitable.
Each year in the past 5 years CHSCP had a positive operating cash flow.
CHSCP Yearly Net Income VS EBIT VS OCF VS FCFCHSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.61%, CHSCP is in line with its industry, outperforming 51.11% of the companies in the same industry.
With a Return On Equity value of 4.76%, CHSCP perfoms like the industry average, outperforming 47.78% of the companies in the same industry.
With a Return On Invested Capital value of 0.05%, CHSCP is not doing good in the industry: 63.33% of the companies in the same industry are doing better.
CHSCP had an Average Return On Invested Capital over the past 3 years of 6.11%. This is significantly below the industry average of 27.81%.
The last Return On Invested Capital (0.05%) for CHSCP is well below the 3 year average (6.11%), which needs to be investigated, but indicates that CHSCP had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROIC 0.05%
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
CHSCP Yearly ROA, ROE, ROICCHSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CHSCP has a Profit Margin of 1.42%. This is comparable to the rest of the industry: CHSCP outperforms 45.56% of its industry peers.
In the last couple of years the Profit Margin of CHSCP has grown nicely.
With a Operating Margin value of 0.02%, CHSCP is not doing good in the industry: 63.33% of the companies in the same industry are doing better.
CHSCP's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 2.99%, CHSCP is not doing good in the industry: 91.11% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CHSCP has remained more or less at the same level.
Industry RankSector Rank
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
CHSCP Yearly Profit, Operating, Gross MarginsCHSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHSCP is creating some value.
The debt/assets ratio for CHSCP is higher compared to a year ago.
CHSCP Yearly Shares OutstandingCHSCP Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCP Yearly Total Debt VS Total AssetsCHSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.23 indicates that CHSCP is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CHSCP (2.23) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.34 indicates that CHSCP is not too dependend on debt financing.
CHSCP has a Debt to Equity ratio (0.34) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.23
ROIC/WACC0.01
WACC4.9%
CHSCP Yearly LT Debt VS Equity VS FCFCHSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

CHSCP has a Current Ratio of 1.40. This is a normal value and indicates that CHSCP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CHSCP (1.40) is comparable to the rest of the industry.
A Quick Ratio of 0.86 indicates that CHSCP may have some problems paying its short term obligations.
CHSCP's Quick ratio of 0.86 is in line compared to the rest of the industry. CHSCP outperforms 43.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.86
CHSCP Yearly Current Assets VS Current LiabilitesCHSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1

3. Growth

3.1 Past

The Revenue has decreased by -8.96% in the past year.
The Revenue has been growing slightly by 4.24% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCP Yearly Revenue VS EstimatesCHSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCP Price Earnings VS Forward Price EarningsCHSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHSCP is valued cheaper than 90.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.83
CHSCP Per share dataCHSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

CHSCP has a Yearly Dividend Yield of 6.93%, which is a nice return.
Compared to an average industry Dividend Yield of 4.61, CHSCP pays a better dividend. On top of this CHSCP pays more dividend than 94.44% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, CHSCP pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.93%

5.2 History

CHSCP has paid a dividend for at least 10 years, which is a reliable track record.
CHSCP has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years21
CHSCP Yearly Dividends per shareCHSCP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CHSCP pays out 32.94% of its income as dividend. This is a sustainable payout ratio.
DP32.94%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCP Yearly Income VS Free CF VS DividendCHSCP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
CHSCP Dividend Payout.CHSCP Dividend Payout, showing the Payout Ratio.CHSCP Dividend Payout.PayoutRetained Earnings

CHS INC - CHSINC 8 PERP

NASDAQ:CHSCP (8/28/2025, 4:10:09 PM)

28.75

-0.14 (-0.48%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-09 2025-07-09
Earnings (Next)11-04 2025-11-04
Inst Owners11.3%
Inst Owner Change-21.43%
Ins Owners0.03%
Ins Owner Change0%
Market Cap352.76M
Analysts0
Price TargetN/A
Short Float %0.16%
Short Ratio1.86
Dividend
Industry RankSector Rank
Dividend Yield 6.93%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP32.94%
Div Incr Years0
Div Non Decr Years21
Ex-Date06-13 2025-06-13 (0.5)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.74
P/B 0.03
P/tB 0.03
EV/EBITDA 3.83
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.32
FCFYN/A
OCF(TTM)38.96
OCFY135.5%
SpS2936.43
BVpS878.97
TBVpS878.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROCE 0.07%
ROIC 0.05%
ROICexc 0.05%
ROICexgc 0.05%
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
FCFM N/A
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
ROICexc(3y)6.66%
ROICexc(5y)4.61%
ROICexgc(3y)6.79%
ROICexgc(5y)4.69%
ROCE(3y)8.06%
ROCE(5y)5.71%
ROICexcg growth 3Y38.36%
ROICexcg growth 5Y-3.28%
ROICexc growth 3Y37.82%
ROICexc growth 5Y-3.23%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
F-Score3
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 5.94
Cap/Depr 131.31%
Cap/Sales 2.22%
Interest Coverage 250
Cash Conversion 77.22%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.86
Altman-Z 2.23
F-Score3
WACC4.9%
ROIC/WACC0.01
Cap/Depr(3y)104.21%
Cap/Depr(5y)89.6%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.27%
Profit Quality(3y)93.36%
Profit Quality(5y)103.6%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-98.83%
EBIT growth 3Y41.53%
EBIT growth 5Y-2.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-109.49%
FCF growth 3Y1.79%
FCF growth 5Y-7.81%
OCF growth 1Y-87.82%
OCF growth 3Y18.88%
OCF growth 5Y2.23%